Protocols
1 protocol(s) meet the specified criteria
Drug: NEOD001
Protocol No.TitleStatus
NEOD001-CL002A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care vs. Placebo Plus Standard of Care in Subjects with Light Chain (AL) AmyloidosisOpen